Reto Ritschard
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Reto Ritschard has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Alfred Zippelius
Laboratory of Cancer Immunology, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland
29 shared publications - Andreas Buser
Regional Blood Transfusion Service, Swiss Red Cross
29 shared publications - Andreas Holbro
Division of Hematology, University Hospital Basel, Basel, Switzerland
29 shared publications - Andreas Zingg
Department of Biomedicine, University Hospital and University of Basel, Basel, Switzerland
29 shared publications - Heinz Läubli
Division of Medical Oncology, University Hospital Basel, Basel, Switzerland
29 shared publications - Helen Thut
Department of Biomedicine, University Hospital and University of Basel, Basel, Switzerland
29 shared publications
Latest Publications
- Open Access
- 2 July 2025
- Published by American Association for Cancer Research (AACR)
Figure S2 from Targeting Cancer-Associated Glycosylation for Adoptive T-cell Therapy of Solid Tumors
- 2 July 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from Targeting Cancer-Associated Glycosylation for Adoptive T-cell Therapy of Solid Tumors
- Open Access
- 2 July 2025
- Published by American Association for Cancer Research (AACR)
Figure S3 from Targeting Cancer-Associated Glycosylation for Adoptive T-cell Therapy of Solid Tumors
- 2 July 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Targeting Cancer-Associated Glycosylation for Adoptive T-cell Therapy of Solid Tumors
- Open Access
- 2 July 2025
- Published by American Association for Cancer Research (AACR)
Figure S4 from Targeting Cancer-Associated Glycosylation for Adoptive T-cell Therapy of Solid Tumors
- 2 July 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from Targeting Cancer-Associated Glycosylation for Adoptive T-cell Therapy of Solid Tumors
- Open Access
- 2 July 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Materials File S1 from Targeting Cancer-Associated Glycosylation for Adoptive T-cell Therapy of Solid Tumors
Plasmid sequences used in this project.
- 2 July 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Materials File S1 from Targeting Cancer-Associated Glycosylation for Adoptive T-cell Therapy of Solid Tumors
Plasmid sequences used in this project.
- Open Access
- 2 July 2025
- Published by American Association for Cancer Research (AACR)
Figure S1 from Targeting Cancer-Associated Glycosylation for Adoptive T-cell Therapy of Solid Tumors
- 2 July 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Targeting Cancer-Associated Glycosylation for Adoptive T-cell Therapy of Solid Tumors
- Open Access
- 2 July 2025
- Published by American Association for Cancer Research (AACR)
Figure S7 from Targeting Cancer-Associated Glycosylation for Adoptive T-cell Therapy of Solid Tumors
- 2 July 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S7 from Targeting Cancer-Associated Glycosylation for Adoptive T-cell Therapy of Solid Tumors
- Open Access
- 2 July 2025
- Published by American Association for Cancer Research (AACR)
Figure S6 from Targeting Cancer-Associated Glycosylation for Adoptive T-cell Therapy of Solid Tumors
- 2 July 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from Targeting Cancer-Associated Glycosylation for Adoptive T-cell Therapy of Solid Tumors
- Open Access
- 2 July 2025
- Published by American Association for Cancer Research (AACR)
Table S1 from Targeting Cancer-Associated Glycosylation for Adoptive T-cell Therapy of Solid Tumors
- 2 July 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1 from Targeting Cancer-Associated Glycosylation for Adoptive T-cell Therapy of Solid Tumors
- Open Access
- 2 July 2025
- Published by American Association for Cancer Research (AACR)
Figure S5 from Targeting Cancer-Associated Glycosylation for Adoptive T-cell Therapy of Solid Tumors
A, Gating strategy for intracellular cytokine staining
- 2 July 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from Targeting Cancer-Associated Glycosylation for Adoptive T-cell Therapy of Solid Tumors
A, Gating strategy for intracellular cytokine staining
- Open Access
- 2 July 2025
- Published by American Association for Cancer Research (AACR)
Figure S8 from Targeting Cancer-Associated Glycosylation for Adoptive T-cell Therapy of Solid Tumors
- 2 July 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S8 from Targeting Cancer-Associated Glycosylation for Adoptive T-cell Therapy of Solid Tumors